NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+5.84%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.31B
AUM Growth
+$3.31B
(+36%)
Cap. Flow
+$835M
Cap. Flow
% of AUM
25.23%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
588
New
19
Increased
514
Reduced
16
Closed
9
Top Buys
| 1 |
Broadcom
AVGO
|
$67.9M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
$64.4M |
| 3 |
Apple
AAPL
|
$36.2M |
| 4 |
Microsoft
MSFT
|
$35.6M |
| 5 |
NVIDIA
NVDA
|
$34.7M |
Top Sells
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$1.21M |
| 2 |
Super Micro Computer
SMCI
|
$812K |
| 3 |
Exelixis
EXEL
|
$572K |
| 4 |
MREO
Mereo BioPharma
MREO
|
$511K |
| 5 |
Vale
VALE
|
$440K |
Sector Composition
| 1 | Technology | 32.75% |
| 2 | Healthcare | 12.38% |
| 3 | Communication Services | 9.77% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
451
DELISTED
SpringWorks Therapeutics
SWTX
| $653K | 0.02% |
20,378
+4,888
| +32% | +$157K |
|
452
Merus
MRUS
$5.01B
| $653K | 0.02% |
13,066
+825
| +7% | +$41.2K |
|
453
Tyler Technologies
TYL
$23.9B
| $650K | 0.02% |
1,113
+15
| +1% | +$8.76K |
|
454
Structure Therapeutics
GPCR
$1.16B
| $650K | 0.02% |
14,801
+5,705
| +63% | +$250K |
|
|
NARI
455
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $650K | 0.02% |
15,750
-29,255
| -65% | -$1.21M |
|
456
Bio-Techne
TECH
$8.31B
| $649K | 0.02% |
8,121
+1,722
| +27% | +$138K |
|
457
Kimco Realty
KIM
$15.1B
| $647K | 0.02% |
27,874
+5,684
| +26% | +$132K |
|
458
Viatris
VTRS
$12.3B
| $641K | 0.02% |
55,178
+11,368
| +26% | +$132K |
|
459
W.W. Grainger
GWW
$48.6B
| $639K | 0.02% |
615
| – | – |
|
460
Denali Therapeutics
DNLI
$2.26B
| $631K | 0.02% |
21,648
| – | – |
|
461
AES
AES
$9.55B
| $628K | 0.02% |
31,323
+6,496
| +26% | +$130K |
|
462
Expeditors International
EXPD
$16.4B
| $628K | 0.02% |
4,777
+812
| +20% | +$107K |
|
463
Aptiv
APTV
$17.1B
| $627K | 0.02% |
8,701
+1,624
| +23% | +$117K |
|
464
Edgewise Therapeutics
EWTX
$1.57B
| $623K | 0.02% |
+23,359
| New | +$623K |
|
465
Monolithic Power Systems
MPWR
$39.4B
| $615K | 0.02% |
665
| – | – |
|
466
Steel Dynamics
STLD
$19B
| $611K | 0.02% |
4,843
+812
| +20% | +$102K |
|
467
Janux Therapeutics
JANX
$1.37B
| $603K | 0.02% |
13,276
+3,553
| +37% | +$161K |
|
468
EQT Corp
EQT
$32.7B
| $602K | 0.02% |
16,425
+3,248
| +25% | +$119K |
|
469
Jacobs Solutions
J
$17.4B
| $590K | 0.02% |
4,506
+812
| +22% | +$106K |
|
470
Waters Corp
WAT
$17.6B
| $576K | 0.02% |
1,600
+210
| +15% | +$75.6K |
|
471
Alexandria Real Estate Equities
ARE
$13.8B
| $574K | 0.02% |
4,836
+812
| +20% | +$96.4K |
|
472
NiSource
NI
$19.8B
| $569K | 0.02% |
16,428
+3,248
| +25% | +$113K |
|
473
Arcturus Therapeutics
ARCT
$453M
| $568K | 0.02% |
24,481
+1,881
| +8% | +$43.7K |
|
474
Arcus Biosciences
RCUS
$1.15B
| $565K | 0.02% |
36,938
+2,332
| +7% | +$35.7K |
|
475
UDR
UDR
$12.7B
| $565K | 0.02% |
12,451
+2,436
| +24% | +$110K |
|